Modulation of chemoselectivity by protein additives. Remarkable effects in the oxidation of hyperforin

Journal of Organic Chemistry

Volumn 69, Issue 23, 2004, Pages 7869-7874

  Verotta, Luisella ^a   Lovaglio, Erminio ^a   Sterner, Olov ^b   Appendino, Giovanni ^c   Bombardelli, Ezio ^d  

^a Dipartimento di Chimica Organica e Industriale   (Italy)

^b Department of Organic Chemistry 2 ^*  (Sweden)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d INDENA S P A   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADDITIVES; DERIVATIVES; MIXTURES; OXIDATION; PROTEINS; REACTION KINETICS;

BIOACTIVITY INDUCTION; HUMAN ALBUMIN; PROTEIN ADDITIVES;

CATALYST SELECTIVITY;

HORSERADISH PEROXIDASE; HUMAN ALBUMIN; HYDROGEN PEROXIDE; HYPERFORIN; LACTONE; OVALBUMIN; PHLOROGLUCINOL; SERUM ALBUMIN;

ARTICLE; CATALYSIS; DRUG ACTIVITY; DRUG SELECTIVITY; OXIDATION; OXIDATION KINETICS; PROTEIN STRUCTURE;

BICYCLO COMPOUNDS; HORSERADISH PEROXIDASE; HYDROGEN PEROXIDE; HYPERICUM; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OVALBUMIN; OXIDATION-REDUCTION; PHLOROGLUCINOL; PROTEINS; SERUM ALBUMIN; TERPENES;

EID: 8644221313     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo048857s     Document Type: Article

References (36)

1. (a) Di Carlo, G.; Borrelli, F.; Ernst, E.; Izzo, A. A. Trends Pharmacol. Sci. 2001, 22, 292-297.
2. (b) AA. VV. Pharmacopsychiatry 2001, 34, Suppl 1.
3. (c) Verotta L. Curr. Top. Med. Chem. 2003, 3, 69-83.
4. (a) Chatterjee, S. S. Bhattacharya, S. K.; Wonnemann, M.; Singer, A.; Muller, W. E. Life Sci. 1998, 63, 499-511.
5. (b) Singer, A.; Wonnemann, M.; Muller, W. E. J. Pharmacol. Exp. Ther. 1999, 290, 1363-1368.
6. (c) Cervo, L.; Rozio, M.; Ekalle-Soppo, C. B.; Guiso, G.; Morazzoni, P.; Caccia, S. Phychopharmacology 2002, 164, 423-428.
7. Schempp, C. M.; Pelz, K.; Wittmer, A.; Schopf, E.; Simon, J. C. Lancet 1999, 353, 2129.
8. Schempp, C. M.; Winghofer, B.; Lüdtke, R.; Simon-Haarhaus, B.; Schöpff, E.; Simon, J. C. Br. J. Dermatol. 2000, 142, 979-984.
9. Schempp, C. M.; Kirkin, V.; Simon-Haarhaus, B.; Kersten, A.; Kiss, J.; Termeer, C. C.; Gilb, B.; Kaufmann, T.; Borner, C.; Sleeman, J. P.; Simon, J. Oncogene 2001, 21, 1242-21250.
10. Hostanska, K.; Reichling, J.; Bommer, S.; Weber, M.; Sailer, R. Eur. J. Pharm. Biopharm. 2003, 56, 121-132.
11. Albert, D.; Zündorf, I.; Dingermann, T.; Müller, W. E.; Steinhilber, D.; Werz, O. Biochem. Pharmacol. 2002, 64, 1767-1775.
12. Heilmann, J.; Winkelmann, K.; Sticher, O. Planta Med. 2003, 69, 202-206.
13. Watkins, R. E.; Maglich, J. M.; Moore, L. B.; Wisely, G. B.; Noble, S. M.; Davis-Searles, P. R.; Lambert, M. H.; Kliewer, S. A.; Redinbo, M. R. Biochemistry 2003, 42, 1430-1438.
14. (b) Moore, L. B.; Goodwin, B.; Jones, S. A.; Wisely, G. B.; Serabjit-Singh, C. J.; Willson, T. M.; Collins, J. L.; Kliewer, S. A. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 7500-7502.
15. (a) Nicolaou, K. C.; Pfeiferkorn, J. A.; Kim, S.; Wei, H. X. J. Am. Chem. Soc. 1999, 121, 4724-4725.
16. (b) Nicolaou, K. C.; Pfefferkorn, J. A.; Cao, G.-Q.; Kim, S.; Kessabi, J. Org. Lett. 1999, 1, 807-810.
17. (c) Usuda, H.; Kanai, M.; Shibasaki, M. Org. Lett. 2002, 4, 859-862.
18. (d) Usuda, H.; Kanai, M.; Shibasaki, M. Tetrahedron Lett. 2002, 43, 3621-3624.
19. (e) Spessard, S. J.; Stoltz, B. M. Org. Lett. 2002, 4, 1943-1946.
20. (f) Kraus, G. A.; Nguyen, T. H.; Jeon, I. Tetrahedron Lett. 2003, 44, 659-661.
21. (a) Verotta, L.; Appendino, G.; Balloro, E.; Jakupovic, J.; Bombardelli, E. J. Nat. Prod. 1999, 62, 770-772.
22. (b) Verotta, L.; Appendino, G.; Jakupovic, J.; Bombardelli, E. J. Nat. Prod. 2000, 63, 412-15.
23. (c) Wolfender, J.-L.; Verotta, L.; Belvisi, L.; Fuzzati, N.; Hostettmann, K. Phytochem. Anal. 2003, 14 (5), 290-297.
24. (d) Verotta, L. Phytochem. Rev. 2002, 389-407.
25. Orth, H. C. J.; Rentel, C.; Schmidt, P. C. J. Pharm. Pharmacol. 1999, 51, 193-200.
26. (a) Gui, Y., Gurley, B., Ang, C. Y. W., Leakey, J. J. Chromatogr. B 2002, 780, 129-135.
27. (b) Cervo, L.; Rozio, M.; Ekalle-Soppo, C. B.; Guiso, G.; Morazzoni, P.; Caccia, S. Psychopharmacology 2002, 164 (4), 423-8.
28. Gui, Y.; Ang, C. Y. W.; Beger, R. D.; Heinze, T. M.; Hu, L.; Leakey, J. Drug Metab. Dispos. 2004, 32, 28-34.
29. Povir, L. F.; Dattagupta, N.; Warf, B. C.; Goldberg, I. H. Biochemistry 1981, 20, 4007-4014.
30. Sono, M.; Roach, M. P.; Coulter, E. D.; Dawson, J. H. Chem. Rev. 1996, 96, 2841-2888.
31. Verotta, L.; Lovaglio, E.; Sterner, O.; Appendino. G.; Bombardelli, E. Eur. J. Org. Chem. 2004, 1193-1197.
32. (a) Banfi, S.; Colonna, S.; Molinari, H.; Juliá S.; Guixer, J. Tetrahedron 1984, 40, 5207 and references therein.
33. For recent reviews see: (b) Lasterra-Sánchez, M. E.; Roberts, S. M. Curr. Org. Chem. 1997, 187. (c) Ebrahim, E.; Wills, M. Tetrahedron: Asymmetry 1997, 8, 3163.
34. For recent reviews see: (b) Lasterra-Sánchez, M. E.; Roberts, S. M. Curr. Org. Chem. 1997, 187. (c) Ebrahim, E.; Wills, M. Tetrahedron: Asymmetry 1997, 8, 3163.
35. Bentley, P. A.; Bickley, J. F.; Roberts, S. M.; Steiner, A. Tetrahedron Lett. 2001, 42, 3741-3743.
36. Bentley, P. A. In Biotransformations; Kelly, D. R., Ed.; Wiley-VCH: Weinheim, 2000; Vol. 8b, Chapter 12, pp 491-517.